Stefan De Buck

Title: **Inventor Spotlight: Stefan De Buck**

Introduction

Stefan De Buck, an innovative inventor based in Basel, Switzerland, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of six patents, his work focuses on advanced treatments for various medical conditions, showcasing his dedication to improving patient care.

Latest Patents

Stefan De Buck's latest patents include groundbreaking methods for treating Sjögren's syndrome. This patent outlines methods for treating the disease using a compound of Formula (I) or a pharmaceutically acceptable salt thereof. Additionally, it discusses medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for treating patients suffering from Sjögren's Syndrome. Another notable patent involves a novel dosage regimen for the administration of a specific compound in the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). This includes details about the compound 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or its pharmaceutically acceptable derivatives.

Career Highlights

Throughout his career, De Buck has worked with prominent companies in the biopharmaceutical sector, including Mereo Biopharma and Ablynx. His experience in these companies has allowed him to collaborate on various projects aimed at developing effective therapeutic solutions.

Collaborations

Stefan has closely collaborated with other industry experts, including Colin Orford and Cyril Clarke. These partnerships have played a crucial role in the advancement of his research and the successful development of his patented innovations.

Conclusion

With a focus on improving treatments for chronic diseases, Stefan De Buck continues to be an influential figure in the realm of pharmaceutical innovations. His dedication to research and development positions him as a leader among inventors working to enhance healthcare outcomes.